Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
451,167
-
Share change
-
-151,088
-
Total reported value
-
$60,728,977
-
Put/Call ratio
-
69%
-
Price per share
-
$134.58
-
Number of holders
-
91
-
Value change
-
-$20,537,996
-
Number of buys
-
31
-
Number of sells
-
40
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2020
As of 31 Mar 2020,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
451,167 shares.
The largest 10 holders included
MORGAN STANLEY, BROWN ADVISORY INC, ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, MURPHY CAPITAL MANAGEMENT INC, COMMONWEALTH EQUITY SERVICES, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
92
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.